DiaSorin S.p.A.
DIA
Kedudukan dalam Saham
#3798
DiaSorin S.p.A. engages in research and development, manufacture, and... DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Harga Saham
$88.31
Disegerakkan terakhir: 2026-10-21
Modal Pasaran
$4.37B
Perubahan (1 hari)
-6.35%
Perubahan (1 tahun)
-2.42%
Negara
IT
Perdagangan DiaSorin S.p.A. (DIA)
Kategori
Healthcare
Sejarah pecahan saham untuk DiaSorin S.p.A. (DIA)
Saham DiaSorin S.p.A. (simbol: DIA) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 22, 2026.
Satu saham DIA yang dibeli sebelum Oct 22, 2026 kini bersamaan dengan 0 saham DIA.
Pecahan saham terkini berlaku pada Oct 22, 2026.
Satu saham DIA yang dibeli sebelum Oct 22, 2026 kini bersamaan dengan 0 saham DIA.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
